Return to homepagePandemic Pact

COVID-19 and influenza vaccine effectiveness against confirmed SARS-CoV-2 using health worker cohorts

Grant number: VMVPT22564

Grant search

Key facts

  • Disease

    COVID-19, Unspecified

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $126,363.93

  • Funder

    Estonian Research Council

  • Principal Investigator

    Uusküla Anneli

  • Research Location

    Estonia

  • Lead Research Institution

    University of Tartu

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Other

  • Occupations of Interest

    Health Personnel

Abstract

This is a prospective multi-country cohort study to measure the effectiveness of the influenza vaccines in hospital-based healthcare workers during a period of co-circulation of influenza and SARS-CoV-2, embedded in the COVID-19 VE study set up under VEBIS, Lot 2. We will assess the feasibility of performing this study in hospital-based HCWs and to validate the use of saliva as an adequate sample for influenza testing in this population.